BCI Can Reach Millions. Neurotech Decided It Shouldn't
•InnovationBCI Can Reach Millions.
•Neurotech Decided It Shouldn'tByTetiana Aleksandrova,Forbes Councils Member.for Forbes Technology CouncilCOUNCIL POSTExpertise from Forbes Councils members, operated under license.
•Opinions expressed are those of the author.
هذا الخبر من Forbes. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
InnovationBCI Can Reach Millions. Neurotech Decided It Shouldn'tByTetiana Aleksandrova,Forbes Councils Member.for Forbes Technology CouncilCOUNCIL POSTExpertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. | Membership (fee-based)May 18, 2026, 10:30am EDTTetiana Aleksandrova is Founder & CEO of brain-computer interface company Subsense Inc. gettyNeurotech is stagnating. Science is advancing, but the patients who need this technology most are still unreached. That gap isn’t biology. It is what has been accepted in our field.Built On A Bad BetA brain-computer interface (BCI) captures neural activity and translates it into control signals for an external device. The most familiar example is a patient with paralysis using their thoughts to move a robotic arm, with the system reading intention and converting it into action in real time.The industry has long accepted who this technology is for: surgical candidates with specific diagnoses and the means to afford invasive procedures. Scalability was never part of the design goal for BCI. The tech got treated as a biological necessity, something baked into the nature of the problem that was made early and never revisited.Today, only a few hundred people have received any form of implanted neural interface, which is a tiny fraction of those living with conditions that BCI could significantly help. Meanwhile, cortical electrode arrays, the gold standard for high-resolution signal capture, cover less than a square centimeter of brain surface. The field has spent decades developing a tool that, by design, can only reach a small portion of the people who need it.That’s the actual problem, not the advancements in electrode materials, compute or regulatory pathways. It was the assumption that BCI wasn’t necessary for all, calcified into benchmarks, funding priorities and research agendas, all reinforcing each other and built on a premise nobody was questioning.When...المصدر: Forbes | Source: Forbes
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Forbes. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Forbes. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.